Use Bacteriostatic Water for multi-dose vials: Tesamorelin (a GHRH analog) is typically supplied as a lyophilized powder, intended to be mixed with Bacteriostatic Water for Injection (0.9% benzyl alcohol) for multi-dose use. Recommended Storage Conditions (Post-Reconstitution) Key Storage Parameters Reconstitution Procedure Storage Comparison: Before vs. After Reconstitution Parameter Lyophilized (Before Reconstitution) Reconstituted Solution Temperature 2–8°C…

This article provides a data-driven comparison of retatrutide (a triple GLP-1/GIP/glucagon receptor agonist in clinical trials) and tirzepatide (a dual GLP-1/GIP agonist approved as Mounjaro/Zepbound). Mechanism of Action Comparison Feature Retatrutide Tirzepatide Receptor targets GLP-1, GIP, Glucagon (triple) GLP-1, GIP (dual) Approval status Investigational (Phase 3 trials) FDA-approved (Mounjaro/Zepbound) Dosing frequency Once weekly (subcutaneous) Once…

KLOW is an 80mg research peptide blend of GHK-Cu, TB-500, BPC-157, and KPV. It expands on the GLOW formula by adding KPV – a gut-lining and immune anti-inflammatory tripeptide – making it ideal for recovery contexts involving gut or systemic inflammation alongside tissue injury.

The Wolverine Stack combines BPC-157 and TB-500 in a single recovery protocol, pairing local healing effects with systemic tissue repair. This guide explains the mechanism, synergy, evidence, and how to approach this popular research peptide combination.

GLOW is a research peptide blend combining GHK-Cu (50mg), TB-500 (10mg), and BPC-157 (10mg) in a single 70mg vial for comprehensive tissue regeneration. This guide explains the mechanism of each component, why they work synergistically, and how GLOW compares to the Wolverine Stack and KLOW.

MOTS-c is a 16-amino acid peptide encoded within the mitochondrial genome that acts as a systemic metabolic hormone. This guide covers what MOTS-c is, how it works through AMPK and the folate-AICAR pathway, its evidence base for insulin sensitivity and longevity, and practical research considerations.

TB-500 is a synthetic 7-amino acid fragment of thymosin beta-4 that promotes tissue repair by binding G-actin, driving cell migration, reducing inflammation, and stimulating new blood vessel formation. This guide explains the mechanism, evidence base, practical considerations, and how it compares to BPC-157 and other repair peptides.

Semaglutide (often abbreviated SEMA) is a long-acting GLP-1 receptor agonist that has transformed the treatment of type 2 diabetes and chronic obesity. This guide explains what semaglutide is, how it works, what the clinical evidence shows, and practical considerations.